株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

世界の再生医療市場:2018年〜2022年

Global Regenerative Medicine Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 321466
出版日 ページ情報 英文 134 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.05円で換算しております。
Back to Top
世界の再生医療市場:2018年〜2022年 Global Regenerative Medicine Market 2018-2022
出版日: 2018年04月16日 ページ情報: 英文 134 Pages
概要

再生医療について

再生医療は、病気や障害、老化の過程で損傷した器官および組織を補強、修復、置換または再生する医療です。

Technavioのアナリストは、2018年から2022年の間に、世界の再生医療市場が18.96%のCAGRで成長すると予測しています。

当レポートでは、再生医療の世界市場について調査し、市場の概要、技術・応用分野・地域別の市場動向、市場規模の推移と予測、成長促進要因ならびに課題の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模の推移と予測

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市場状況

第7章 世界の再生医療市場:技術別

  • 市場区分:技術別
  • 市場比較:技術別
  • 細胞・組織治療
  • 遺伝子治療
  • 市場機会:技術別

第8章 世界の再生医療市場:応用分野別

  • 市場区分:応用分野別
  • 市場比較:応用分野別
  • 筋骨格
  • 皮膚
  • 心血管
  • その他
  • 市場機会:応用分野別

第9章 顧客情勢

第10章 地域情勢

  • 市場区分:地域別
  • 市場比較:地域別
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋
  • 市場機会

第11章 意思決定の枠組み

第12章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第13章 市場動向

  • 臨床試験数の増加
  • 新技術の進歩
  • 戦略的パートナーシップと買収

第14章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競合情勢

第15章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • ALLERGAN
  • Integra LifeSciences
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet

第16章 付録

図表
  • Exhibit 01: Global medical devices market: Market size 2017
  • Exhibit 02: Global medical devices market: Segmentation
  • Exhibit 03: Market characteristics
  • Exhibit 04: Global regenerative medicine market: Segmentation
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global regenerative medicine market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global regenerative medicine market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global regenerative medicine market - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global regenerative medicine market by technology - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by technology
  • Exhibit 20: Global regenerative medicine market by cell and tissue-based therapy - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global regenerative medicine market by cell and tissue-based therapy - Year over year growth 2018-2022 (%)
  • Exhibit 22: Approved gene therapy products
  • Exhibit 23: Global regenerative medicine market by gene therapy - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Global regenerative medicine market by gene therapy - Year over year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by technology
  • Exhibit 26: Global regenerative medicine market: Segmentation by application 2017 (% share)
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global regenerative medicine market by region - Market share 2017-2022 (%)
  • Exhibit 29: Global regenerative medicine market: Regional comparison
  • Exhibit 30: Regenerative medicine market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Regenerative medicine market in Americas - Year over year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: Regenerative medicine market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: Regenerative medicine market in EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: Regenerative medicine market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: Regenerative medicine market in APAC - Year over year growth 2018-2022 (%)
  • Exhibit 38: Top three countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: ALLERGAN - Overview
  • Exhibit 46: ALLERGAN - Business segments
  • Exhibit 47: ALLERGAN - Organizational developments
  • Exhibit 48: ALLERGAN - Geographic focus
  • Exhibit 49: ALLERGAN - Segment focus
  • Exhibit 50: ALLERGAN - Key offerings
  • Exhibit 51: ALLERGAN - Key customers
  • Exhibit 52: Integra LifeSciences - Overview
  • Exhibit 53: Integra LifeSciences - Business segments
  • Exhibit 54: Integra LifeSciences - Organizational developments
  • Exhibit 55: Integra LifeSciences - Geographic focus
  • Exhibit 56: Integra LifeSciences - Segment focus
  • Exhibit 57: Integra LifeSciences - Key offerings
  • Exhibit 58: Integra LifeSciences - Key customers
  • Exhibit 59: Medtronic - Overview
  • Exhibit 60: Medtronic - Business segments
  • Exhibit 61: Medtronic - Organizational developments
  • Exhibit 62: Medtronic - Geographic focus
  • Exhibit 63: Medtronic - Segment focus
  • Exhibit 64: Medtronic - Key offerings
  • Exhibit 65: Medtronic - Key customers
  • Exhibit 66: MiMedx Group - Overview
  • Exhibit 67: MiMedx Group - Business segments
  • Exhibit 68: MiMedx Group - Organizational developments
  • Exhibit 69: MiMedx Group - Geographic focus
  • Exhibit 70: MidMedx Group - Segment focus
  • Exhibit 71: MidMedx Group - Key offerings
  • Exhibit 72: MiMedx Group - Key customers
  • Exhibit 73: Organogenesis - Overview
  • Exhibit 74: Organogenesis - Business segments
  • Exhibit 75: Organogenesis - Organizational developments
  • Exhibit 76: Organogenesis - Geographic focus
  • Exhibit 77: Organogenesis - Segment focus
  • Exhibit 78: Organogenesis - Key offerings
  • Exhibit 79: Organogenesis - Key customers
  • Exhibit 80: Zimmer Biomet - Overview
  • Exhibit 81: Zimmer Biomet - Business segments
  • Exhibit 82: Zimmer Biomet - Organizational developments
  • Exhibit 83: Zimmer Biomet - Geographic focus
  • Exhibit 84: Zimmer Biomet - Segment focus
  • Exhibit 85: Zimmer Biomet - Key offerings
  • Exhibit 86: Zimmer Biomet - Key customers
目次
Product Code: IRTNTR21891

About Regenerative Medicine

Regenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.

Technavio's analysts forecast the global regenerative medicine market to grow at a CAGR of 18.96% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Regenerative Medicine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ALLERGAN
  • Integra LifeSciences
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet

Market driver

  • Increasing prevalence of chronic diseases
  • For a full, detailed list, view our report

Market challenge

  • Uncertain regulatory approval
  • For a full, detailed list, view our report

Market trend

  • Emerging technological advances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY

  • Segmentation by technology
  • Comparison by technology
  • Global regenerative medicine market by cell and tissue-based therapy
  • Global regenerative medicine market by gene therapy
  • Market opportunity by technology
  • Segmentation by application

PART 08: MARKET SEGMENTATION BY APPLICATION

  • Global regenerative medicine market by musculoskeletal application
  • Global regenerative medicine market by dermatology application
  • Global regenerative medicine market by cardiovascular application
  • Global regenerative medicine market by other applications

PART 09: CUSTOMER LANDSCAPE

  • Geographical segmentation

PART 10: REGIONAL LANDSCAPE

  • Regional comparison
  • Regenerative medicine market in Americas - Market size and forecast 2017-2022
  • Regenerative medicine market in EMEA - Market size and forecast 2017-2022
  • Regenerative medicine market in APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Increasing number of clinical trials
  • Emerging technological advances
  • Strategic partnerships and acquisitions

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Integra LifeSciences
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet

PART 16: APPENDIX

  • List of abbreviations
Back to Top